Yadi Wang

Yadi Wang

Auto-generated profile, based on publicly available information

Yadi Wang

College of Pharmacy

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2008 in Clinical and Vaccine Immunology
Verified
Journal Article
Open access
PDF file
WHWei Hao
Wei Hao
YPYu-Xian Pan
Yu-Xian Pan
YDYanqing Ding
Yanqing Ding
SXSha Xiao
Sha Xiao
KYKai Yin
Kai Yin
XCXiao-Yan Che
Xiao-Yan Che
The diagnosis of invasive aspergillosis (IA) based on the detection of Aspergillus galactomannan (GM) is complicated by the presence of cross-reactive GM epitopes in patient specimens. We have developed a novel and specific Aspergillus antigen-capture enzyme-linked immunosorbent assay (ELISA) by the selection of two well-characterized monoclonal antibodies from 17 candidate antibodies. The epitopes recognized by the monoclonal antibodies were present on the cell walls of the hyphae and the conidia of Aspergillus species, which were circulating or excreted as immunodominant antigens during the acute phase of IA established in the animal models. The detection of experimental Aspergillus-mediated antigenemia was suitably sensitive, and the sensitivity was comparable to that of a commercial GM detection ELISA kit (the Platelia Aspergillus assay). Moreover, the specificity of this assay was 100% when it was used to test 382 serum specimens and 120 urine specimens from healthy individuals. Cross-reactivity with other common opportunistic fungi, such as Penicillium and Candida species, and with purified GM protein derived from Aspergillus was not evident. Therefore, the chemical nature of the epitopes captured in this assay is most likely not associated with the GM structure, indicating that this newly developed Aspergillus antigen-capture ELISA is a promising tool for the diagnosis of IA without the risk of the false-positive results that are problematic with current GM antigen assays.

23 June 2017 in Cancer Biomarkers
Verified
Journal Article
Closed access
PDF file
LXLiying Xue
Liying Xue
JNJinglong Nan
Jinglong Nan
DLDong Li
Dong Li
CZCuiying Zhang
Cuiying Zhang
HLHui Li
Hui Li
YWYadi Wang
Yadi Wang
BACKGROUND: Esophageal squamous cell carcinoma (ESCC) is one of the most common cause of cancer-associated mortality. Uncovering novel molecular biomarkers that can predict ESCC development will improve personalized therapy. OBJECTIVE: The goal of th


30 November 2022 in Current Opinion in Food Science
Verified
Journal Article
Closed access
YLYonglu Li
Yonglu Li
YWYadi Wang
Yadi Wang
PLPing Li
Ping Li
QZQingqing Zhou
Qingqing Zhou
Xiaodong ZhengXiaodong Zheng
Xiaodong Zheng
QGQing Gu
Qing Gu

29 September 2020 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
YWYadi Wang
Yadi Wang
YWYue Wang
Yue Wang
JQJiang Qian
Jiang Qian
XPXiaohong Pan
Xiaohong Pan
XLXueling Li
Xueling Li
JLJunhong Lü
Junhong Lü
Single-cell infrared phenomics was conceptually demonstrated as a novel strategy of phenotypic screening for drug discovery with infrared microspectroscopy.

13 October 2014 in Technology in Cancer Research & Treatment
Verified
Journal Article
Open access
FZFuli Zhang
Fuli Zhang
YWYadi Wang
Yadi Wang
WXWeidong Xu
Weidong Xu
HJHuayong Jiang
Huayong Jiang
QLQingzhi Liu
Qingzhi Liu
HHHeliang He
Heliang He
Intensity-modulated radiotherapy (IMRT) potentially leads to a more favorite dose distribution compared to 3-dimensional or conventional tangential radiotherapy (RT) for breast cancer after conservative surgery or mastectomy. The aim of this study was to compare dosimetric parameters of the planning target volume (PTV) and organs at risk (OARs) among helical tomotherapy (HT), inverse-planned IMRT (IP-IMRT), and forward-planned field in field (FP-FIF) IMRT techniques after breast-conserving surgery. Computed tomography scans from 20 patients (12 left sided and 8 right sided) previously treated with T1N0 carcinoma were selected for this dosimetric planning study. We designed HT, IP-IMRT, and FP-FIF plans for each patient. Plans were compared according to dose–volume histogram analysis in terms of PTV homogeneity and conformity indices (HI and CI) as well as OARs dose and volume parameters. Both HI and CI of the PTV showed statistically significant difference among IP-IMRT, FP-FIF, and HT with those of HT were best (P < .05). Compared to FP-FIF, IP-IMRT showed smaller exposed volumes of ipsilateral lung, heart, contralateral lung, and breast, while HT indicated smaller exposed volumes of ipsilateral lung but larger exposed volumes of contralateral lung and breast as well as heart. In addition, HT demonstrated an increase in exposed volume of ipsilateral lung (except for fraction of lung volume receiving >30 Gy and 20 Gy), heart, contralateral lung, and breast compared with IP-IMRT. For breast cancer radiotherapy (RT) after conservative surgery, HT provides better dose homogeneity and conformity of PTV compared to IP-IMRT and FP-FIF techniques, especially for patients with supraclavicular lymph nodes involved. Meanwhile, HT decreases the OAR volumes receiving higher doses with an increase in the volumes receiving low doses, which is known to lead to an increased rate of radiation-induced secondary malignancies. Hence, composite factors including dosimetric advantage, clinical effect, and economic burden should be taken into comprehensive consideration when choosing an RT technique in clinical practice.